Over-the-counter antihistamine medication on a counter for a blog post about antihistamines for PMDD and perimenopause

The Zyrtec and Pepcid Trend, Explained

June 03, 20265 min read

Famotidine and cetirizine for PMDD and perimenopause: what the evidence actually shows

A few patients asked me last month whether they should try taking Pepcid and Zyrtec for their PMS/PMDD (premenstrual syndrome/premenstrual dysphoric disorder) or perimenopause. They have seen it on TikTok and Instagram. The idea is making the rounds, and the internet is doing its usual job of running well ahead of the evidence. But let’s talk about it and you can decide if it’s something worth your time.

What people are actually talking about

The two medications come up together. Cetirizine (Zyrtec) is an H1 blocker, the kind of antihistamine you take for seasonal allergies. Famotidine (Pepcid) is an H2 blocker, the kind you take for heartburn. Both block histamine, just at different receptors and in different parts of the body.

The theory going around is that if you block both, you cover more of the symptoms that flare in the second half of the cycle (luteal phase) or during the menopause transition. The mood changes, the sleep trouble, the bloating, the headaches.

Why the idea isn't crazy

There is a potential mechanism here.

Estrogen acts on mast cells, the immune cells that release histamine, and it tends to rev them up. Mast cells carry estrogen receptors, and when estrogen binds, they release more histamine. There is even a feedback loop, where histamine nudges estrogen production in turn. Mast cell numbers in the uterus rise and fall across the menstrual cycle. And histamine touches some of the same brain chemistry, serotonin and dopamine and GABA, that we know is involved in the mood symptoms of PMDD.

In perimenopause, estrogen swings erratically rather than declining in a smooth line. It is reasonable to think those swings could stir up histamine sensitivity along the way.

So the mechanism is plausible. I am not dismissing it. But plausible and proven are two different things, and the gap between them is where we should be careful.

What the evidence shows for PMDD

For PMDD specifically. there are no clinical trials. None. Not for cetirizine, not for famotidine, not for the two together.

What exists is a 2023 opinion paper that argued H1 antihistamines were worth studying for PMDD, based on the histamine biology above. That is a hypothesis. It is a reasonable one. It is not evidence that the treatment works. Sedating antihistamines like diphenhydramine (Benadryl) get used off-label for luteal-phase sleep trouble, but that practice rests on clinical habit, not on trials either.

The combination of cetirizine plus famotidine, the one going around online, has never been studied for PMDD in any form.

What the evidence shows for perimenopause

This is where there is at least a little data, though not much.

One small randomized trial, published in 2003, tested cetirizine for hot flashes in 50 postmenopausal women. The women on cetirizine had about a 40% reduction in hot flash scores, compared to about 9% on placebo. That is a real result.

It is also one study, with 50 women, more than twenty years ago, that no one has repeated. The International Menopause Society calls cetirizine "promising" for hot flashes and then says, correctly, that we are waiting on more studies. It does not appear in the major US guidelines as a recommended treatment for hot flashes, where the better-supported non-hormonal options are SSRIs (selective serotonin reuptake inhibitors aka anti-depressants), SNRIs (selective norepinephrine reuptake inhibitors aka anti-depressants), gabapentin, and fezolinetant/elinzanetate..

So: one encouraging trial, never replicated, not yet in the guidelines. That’s all we have in the evidence base.

We also have lots of social media anecdotal evidence, sure. But we all know that social media doesn’t always tell the whole truth. Women who once posted that something is helping may not post later that it actually isn’t working or is causing unwanted side effects. As much as it feels like good evidence, it isn’t. It is biased towards exciting outsized improvements that garner clicks and it is never a good idea to base health decisions on that kind of data..

What I actually do with this in clinic

Cetirizine and famotidine are both available over the counter, both inexpensive, and both well tolerated by most healthy women when taken for their approved uses. The second-generation antihistamines like cetirizine and loratadine do not carry the heart-rhythm and sedation concerns that the older ones like Benadryl do. Famotidine has a low side-effect burden on its own.

The one combination I do pay attention to is if you are also on an SSRI, particularly citalopram or escitalopram, which can affect your heart's QT interval. That is worth a conversation, not alarm, and it is a reason to have someone who knows your full medication list in the loop rather than assembling the regimen yourself.

I would not reach for antihistamines in place of the treatments we actually have evidence for. If you have PMDD that is disrupting your life, the things that are proven to help, SSRIs dosed in the luteal phase or continuously (because who can remember to take something 14 days out of the month??), certain birth control pills, are worth a real look first. If you are dealing with hot flashes, hormone therapy and the established non-hormonal options have far more behind them than one small study abstract from 2003.

But if you are a healthy woman already taking cetirizine and famotidine and it isn't hurting you, I am not going to tell you to stop. And if you wanted to try it and there weren't any contraindications, it might be safe to try after talking with your doctor.

This is an area where the research is genuinely behind the conversation. That happens. It does not make the idea wrong, and it does not make it right. It makes it unproven. Taking it for this reason would be an experiment and with any experiment you need to be informed before deciding to participate.


If you would like to sort through your own version of this with a doctor who has time to actually go through your symptoms, your medication list, and what the evidence does and doesn't support, the discovery call is fifteen minutes, no charge, and no pressure to do anything afterward. We can talk through whether becoming a patient at Sorrel Health and Wellness is right for you.

[Book your discovery call →]

Dr. Meghan Tierney

Dr. Meghan Tierney

Dr. Meghan Tierney is board certified in Family Medicine and Obesity Medicine and is a Menopause Society Certified Practitioner. She is the founder of Sorrel Health & Wellness, where she provides evidence-based, trauma-informed care for women in midlife, with a focus on metabolic health, hormone changes, and sustainable, shame-free treatment that fits real life.

LinkedIn logo icon
Instagram logo icon
Youtube logo icon
Back to Blog